| Sep 6 |
Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
|
| Sep 6 |
Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript)
|
| Sep 4 |
Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
| Aug 28 |
Editas Medicine to Participate in Upcoming Investor Conferences
|
| Aug 15 |
We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate
|
| Aug 8 |
BofA upgrades Editas to buy, cites reni-cel progress
|
| Aug 8 |
Editas (EDIT) Q2 Earnings & Revenues Miss Estimates, Stock Down
|
| Aug 8 |
Q2 2024 Editas Medicine Inc Earnings Call
|
| Aug 7 |
Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
|
